Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Biohaven Pharmaceutical Holding Company Ltd.
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
IPO Date: May 11, 2017
Sector: Healthcare
Industry: Biotech
Market Cap: $2.1B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.24 | 2.60%
Avg Daily Range (30 D): $1.03 | 4.68%
Avg Daily Range (90 D): $1.01 | 3.37%
Institutional Daily Volume
Avg Daily Volume: .71M
Avg Daily Volume (30 D): 1.63M
Avg Daily Volume (90 D): 1.12M
Trade Size
Avg Trade Size (Sh.): 79
Avg Trade Size (Sh.) (30 D): 78
Avg Trade Size (Sh.) (90 D): 68
Institutional Trades
Total Inst.Trades: 5,115
Avg Inst. Trade: $3.12M
Avg Inst. Trade (30 D): $2.18M
Avg Inst. Trade (90 D): $2.55M
Avg Inst. Trade Volume: .06M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $5.02M
Avg Closing Trade (30 D): $4.02M
Avg Closing Trade (90 D): $5.21M
Avg Closing Volume: 102.12K
       
News
Apr 25, 2025 @ 9:10 PM
Why Biohaven Stock Plummeted by More Than 15% Toda...
Source: Eric Volkman
Apr 14, 2025 @ 2:04 AM
BHVN Investors Have Opportunity to Join Biohaven L...
Source: Business Wire
Apr 12, 2025 @ 1:30 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: N/A
Apr 8, 2025 @ 6:17 PM
Argenx's Flagship Drug Vyvgart Shows Sustained Dis...
Source: Vandana Singh
Apr 3, 2025 @ 1:30 PM
Why Biotech Stocks Such as Biohaven, Recursion Pha...
Source: The Motley Fool
Financials
  TTM Q2 2024 Q1 2024
Basic EPS $-1.7 $-3.64 $-2.2
Diluted EPS $-1.7 $-3.64 $-2.2
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -160.3M $ -319.77M $ -179.5M
Operating Income / Loss $ -178.17M $ -333.77M $ -183.24M
Cost of Revenue $ $ $
Net Cash Flow $ -154.3M $ 55.39M $ -65.19M
PE Ratio